0001628280-26-008322
SEC filingIQVIA Holdings Inc. reported strong financial results for fiscal year 2025, with revenues of $16.31 billion and net income of $1.36 billion. The company generated operating income of $2.18 billion, representing an operating margin of 13.4%. Cash flow from operations was robust at $2.65 billion, supporting significant investment activities including $1.71 billion in business acquisitions and $603 million in property, equipment, and software. The balance sheet shows total assets of $29.94 billion, with substantial goodwill of $16.62 billion and total debt of $15.72 billion. The company maintained strong liquidity with $1.98 billion in cash and cash equivalents. Earnings per share were $8.00 for both basic and diluted calculations. These results demonstrate IQVIA's continued growth in the healthcare data and analytics sector, supported by strategic investments and operational efficiency.
IQVIA Holdings Inc. delivered solid financial performance for fiscal year 2025, reporting revenues of $16.31 billion and net income of $1.36 billion. The company achieved operating income of $2.18 billion, representing an operating margin of 13.4%. Gross profit totaled $5.43 billion with a gross margin of 33.3%. Earnings per share were $8.00 for both basic and diluted calculations, based on weighted average shares outstanding of 171.9 million basic and 173.5 million diluted. The company maintained strong cash generation with operating cash flow of $2.65 billion, which supported significant investment activities throughout the year.
The company reported total revenues of $16.31 billion for fiscal year 2025. Cost of revenues, exclusive of depreciation and amortization, was $10.88 billion. The document does not provide segment breakdown or geographic mix data for revenue analysis. No specific growth drivers or segment performance details are disclosed in the provided financial data. The revenue figure represents the consolidated total for IQVIA's operations across all business activities.
IQVIA achieved a gross margin of 33.3% with gross profit of $5.43 billion on revenues of $16.31 billion. Operating margin was 13.4% with operating income of $2.18 billion. The cost structure included selling, general and administrative expenses of $2.00 billion, depreciation and amortization of $1.14 billion, and restructuring costs of $105 million. Interest expense was $729 million, while interest income was $45 million. The company reported other income, net of $99 million and equity in earnings of unconsolidated affiliates of $22 million.
Operating activities generated $2.65 billion in cash, primarily from net income of $1.36 billion adjusted for non-cash items including depreciation and amortization of $1.14 billion. Investing activities used $2.31 billion, including $1.71 billion for business acquisitions and $603 million for property, equipment and software. Financing activities used $150 million, with $1.24 billion spent on common stock repurchases. The balance sheet shows total assets of $29.94 billion, including $16.62 billion in goodwill and $4.96 billion in other identifiable intangibles. Total liabilities were $23.31 billion, with total debt of $15.72 billion. Stockholders' equity was $6.63 billion.
The provided financial data does not include management guidance, strategic priorities, or specific risk factors for future periods. The document focuses on historical financial results for fiscal year 2025 without forward-looking statements or outlook commentary. Investors should refer to the complete 10-K filing for comprehensive risk factor disclosures and management discussion of future prospects.